Sponsored Links
| Lucentis(R) (Ranibizumab) Launched In The UK For The Treatment Of Vision Loss Due To Macular Oedema Secondary To Retinal Vein Occlusion (RVO) |
 |
 |
 |
| Medical News - Eye Health | |||
|
Novartis Pharmaceuticals UK Ltd today announced that Lucentis® (ranibizumab) has launched in the UK for the treatment of visual impairment due to macular oedema secondary to Retinal Vein Occlusion (RVO)... Read more: Eye Health / Blindness News From Medical News Today
|